4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-21-021915
Options or other derivatives
- Chief Financial Officer acquired 250,001 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Amman Bradford K. Chief Financial Officer | 2021-08-31 | Grant or award · Stock Option (Right to Buy) | +50,000 | $5.26 | $263,000 | 50,000 | D |
| Amman Bradford K. Chief Financial Officer | 2021-03-12 | Grant or award · Stock Option (Right to Buy) | +100,000 | $7.50 | $750,000 | 100,000 | D |
| Amman Bradford K. Chief Financial Officer | 2019-11-18 | Grant or award · Stock Option (Right to Buy) | +16,667 | $7.50 | $125,003 | 16,667 | D |
| Amman Bradford K. Chief Financial Officer | 2018-10-22 | Grant or award · Stock Option (Right to Buy) | +83,334 | $7.50 | $625,005 | 83,334 | D |
Loading xslF345X03/ownership.xml…